Psychiatric Consultation Through Videoconference in a Primary Care Setting

The recruitment status of this study is unknown because the information has not been verified recently.

Verified May 2008 by Sha’ar Menashe Mental Health Center.
Recruitment status was Not yet recruiting

Sponsor:

Collaborator:

Galil Center for Telemedicine and Medical Informatics

Information provided by:

Sha’ar Menashe Mental Health Center

ClinicalTrials.gov Identifier:

NCT00298961

First received: March 2, 2006

Last updated: May 20, 2008

Last verified: May 2008

History of Changes

Purpose

In our study we will aim to examine the issues of cost analysis, quality of life, clinical efficacy and satisfaction of psychiatric consultations through videoconference in a primary care setting in comparison with in-person psychiatric treatment and primary care only. The main hypotheses of the study are: Satisfaction of the patients will increase, the use of telepsychiatry will reduce the costs for the primary and mental health care centers as well as for the patients, the treatment will be as effective as in-person treatment, the number of patients referred to mental health treatment will be higher than that of the previous year, quality of life will improve and that there will be a stigma reduction of mental illness.

Condition	Intervention
Remote Consultation Community Psychiatry	Device: Videoconference equipment FALCON/IP

Study Type:	Interventional
Study Design:	Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment
Official Title:	Telepsychiatry: Cost Analysis, Quality of Life, Satisfaction and Effectiveness of Psychiatric Consultation Through Videoconference in a Primary Care Setting

Resource links provided by NLM:

MedlinePlus related topics: Mental Health

U.S. FDA Resources

Further study details as provided by Sha’ar Menashe Mental Health Center:

Primary Outcome Measures:

Brief Psychiatric Rating Scale (BPRS) at 0 months, 6 months and 12 months.

Secondary Outcome Measures:

Clinical Global Impression Scale (CGI) at 0 months, 6 months and 12 months.
Hamilton Anxiety Rating Scale (HAM-A) at 0 months, 6 months and 12 months.
Hamilton Depression Rating Scale (HAM-D) at 0 months, 6 months and 12 months.
Global satisfaction questionnaire at 0 months, 6 months and 12 months.
General Health Questionnaire 11 (GHQ11) at 0 months, 6 months and 12 months.
Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q-18) at 0 months, 6 months and 12 months.
Costs: Travel expenses, extra consultations, hospitalizations, Medication, loss of work days, medical visitations, ancillary tests such as ECG, lab tests and others at 0 months, 6 months and 12 months.

Estimated Enrollment:	160
Study Start Date:	May 2006
Estimated Study Completion Date:	November 2007

Show Detailed Description

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Patients referred by the primary care physician.
Age 18 and over.
Speak Hebrew.

Exclusion Criteria:

Patients that suffer from severe dementia.
Patients suffering from addiction to drugs or alcohol.
Patients who are deaf, dumb or blind.
Patients who have a legal guardian.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00298961

Contacts

Contact: Mahmud Jabarin, MD	+972-4-6278110	jabarin@shaar-menashe.org.il
Contact: Ehud Susser, MD	+972-4-6278946	udiwudi@yahoo.com

Locations

Israel
Sha'ar Menashe Mental Health Center Ambulatory Clinic	Recruiting
Hadera, Israel, 38814
Contact: Mahmud Jabarin, MD +972-4-6278110 jabarin@shaar-menashe.org.il
Contact: Ehud Susser, MD +972-4-6278946 udiwudi@yahoo.com
Principal Investigator: Mahmud Jabarin, MD

Sponsors and Collaborators

Sha’ar Menashe Mental Health Center

Galil Center for Telemedicine and Medical Informatics

Investigators

Principal Investigator:	Mahmud Jabarin, MD	Sha'ar Menashe Mental Health Center, Israel
Study Chair:	Ilan Modai, MD, MHA	Sha'ar Menashe Mental Health Center, Israel
Study Chair:	Ehud Susser, MD	Sha'ar Menashe Mental Health Center, Israel

More Information

Publications:

Hyler SE, Gangure DP, Batchelder ST. Can telepsychiatry replace in-person psychiatric assessments? A review and meta-analysis of comparison studies. CNS Spectr. 2005 May;10(5):403-13. Review.

Frueh BC, Deitsch SE, Santos AB, Gold PB, Johnson MR, Meisler N, Magruder KM, Ballenger JC. Procedural and methodological issues in telepsychiatry research and program development. Psychiatr Serv. 2000 Dec;51(12):1522-7.

Hilty DM, Luo JS, Morache C, Marcelo DA, Nesbitt TS. Telepsychiatry: an overview for psychiatrists. CNS Drugs. 2002;16(8):527-48. Review.

May C, Gask L, Atkinson T, Ellis N, Mair F, Esmail A. Resisting and promoting new technologies in clinical practice: the case of telepsychiatry. Soc Sci Med. 2001 Jun;52(12):1889-901.

Monnier J, Knapp RG, Frueh BC. Recent advances in telepsychiatry: an updated review. Psychiatr Serv. 2003 Dec;54(12):1604-9. Review.

Williams TL, May CR, Esmail A. Limitations of patient satisfaction studies in telehealthcare: a systematic review of the literature. Telemed J E Health. 2001 Winter;7(4):293-316. Review.

Roine R, Ohinmaa A, Hailey D. Assessing telemedicine: a systematic review of the literature. CMAJ. 2001 Sep 18;165(6):765-71. Review.

Simpson J, Doze S, Urness D, Hailey D, Jacobs P. Telepsychiatry as a routine service--the perspective of the patient. J Telemed Telecare. 2001;7(3):155-60.

Yoshino A, Shigemura J, Kobayashi Y, Nomura S, Shishikura K, Den R, Wakisaka H, Kamata S, Ashida H. Telepsychiatry: assessment of televideo psychiatric interview reliability with present- and next-generation internet infrastructures. Acta Psychiatr Scand. 2001 Sep;104(3):223-6.

Dongier M, Tempier R, Lalinec-Michaud M, Meunier D. Telepsychiatry: psychiatric consultation through two-way television. A controlled study. Can J Psychiatry. 1986 Feb;31(1):32-4.

Cruz M, Krupinski EA, Lopez AM, Weinstein RS. A review of the first five years of the University of Arizona telepsychiatry programme. J Telemed Telecare. 2005;11(5):234-9.

Hyler SE, Gangure DP. A review of the costs of telepsychiatry. Psychiatr Serv. 2003 Jul;54(7):976-80.

Krupinski EA, Barker G, Lopez AM, Weinstein RS. An analysis of unsuccessful teleconsultations. J Telemed Telecare. 2004;10(1):6-10.

Hilty DM, Marks SL, Urness D, Yellowlees PM, Nesbitt TS. Clinical and educational telepsychiatry applications: a review. Can J Psychiatry. 2004 Jan;49(1):12-23. Review.

Kennedy C, Yellowlees P. A community-based approach to evaluation of health outcomes and costs for telepsychiatry in a rural population: preliminary results. J Telemed Telecare. 2000;6 Suppl 1:S155-7.

ClinicalTrials.gov Identifier:	NCT00298961 History of Changes
Other Study ID Numbers:	TelepsychiatryCTIL
Study First Received:	March 2, 2006
Last Updated:	May 20, 2008
Health Authority:	Israel: Israeli Health Ministry Pharmaceutical Administration

ClinicalTrials.gov processed this record on June 17, 2013

To Top